Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Secondary efficacy results from the phase II LIGHT study Meeting Abstract


Authors: Cadoo, K.; Simpkins, F.; Mathews, C.; Liu, Y.; Provencher, D.; McCormick, C.; ElNaggar, A.; Kabil, N.; Bennett, J.; Yu, H.; Munley, J.; Aghajanian, C.
Abstract Title: Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Secondary efficacy results from the phase II LIGHT study
Meeting Title: 2021 Society of Gynecologic Oncology - 52nd Annual Meeting on Women's Cancer
Journal Title: Gynecologic Oncology
Volume: 162
Issue: Suppl. 1
Meeting Dates: 2021 Mar 19-25
Meeting Location: Virtual
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 2021-08-01
Start Page: S217
Language: English
ACCESSION: WOS:000687070800410
PROVIDER: wos
DOI: 10.1016/S0090-8258(21)01064-7
Notes: Meeting Abstract: 413 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karen Anne Cadoo
    113 Cadoo
  2. Ying Liu
    105 Liu